Optimized quantification of intra-host viral diversity in SARS-CoV-2 and influenza virus sequence data

被引:9
|
作者
Roder, A. E. [1 ]
Johnson, K. E. E. [1 ,2 ]
Knoll, M. [2 ]
Khalfan, M. [2 ]
Wang, B. [2 ]
Schultz-Cherry, S. [3 ]
Banakis, S. [1 ]
Kreitman, A. [1 ]
Mederos, C. [1 ]
Youn, J. -H. [4 ]
Mercado, R. [4 ]
Wang, W. [1 ]
Chung, M. [1 ]
Ruchnewitz, D. [5 ]
Samanovic, M. I. [6 ]
Mulligan, M. J. [6 ]
Laessig, M. [5 ]
Luksza, M. [7 ]
Das, S. [4 ]
Gresham, D. [2 ]
Ghedin, E. [1 ,2 ]
机构
[1] NIAID, Syst Genom Sect, Lab Parasit Dis, DIR,NIH, Bethesda, MD 20892 USA
[2] NYU, Ctr Genom & Syst Biol, Dept Biol, New York, NY 10012 USA
[3] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN USA
[4] NIH, Dept Lab Med, Bethesda, MD USA
[5] Univ Cologne, Inst Biol Phys, Cologne, Germany
[6] NYU, Langone Vaccine Ctr, Dept Med, New York, NY USA
[7] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY USA
来源
MBIO | 2023年 / 14卷 / 04期
关键词
SARS-CoV-2; influenza; genomics; bioinformatics; RNA; SELECTION; EVOLUTION; MUTATION; CANCER;
D O I
10.1128/mbio.01046-23
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
High error rates of viral RNA-dependent RNA polymerases lead to diverse intra-host viral populations during infection. Errors made during replication that are not strongly deleterious to the virus can lead to the generation of minority variants. However, accurate detection of minority variants in viral sequence data is complicated by errors introduced during sample preparation and data analysis. We used synthetic RNA controls and simulated data to test seven variant-calling tools across a range of allele frequencies and simulated coverages. We show that choice of variant caller and use of replicate sequencing have the most significant impact on single-nucleotide variant (SNV) discovery and demonstrate how both allele frequency and coverage thresholds impact both false discovery and false-negative rates. When replicates are not available, using a combination of multiple callers with more stringent cutoffs is recommended. We use these parameters to find minority variants in sequencing data from SARS-CoV-2 clinical specimens and provide guidance for studies of intra-host viral diversity using either single replicate data or data from technical replicates. Our study provides a framework for rigorous assessment of technical factors that impact SNV identification in viral samples and establishes heuristics that will inform and improve future studies of intra-host variation, viral diversity, and viral evolution. IMPORTANCEWhen viruses replicate inside a host cell, the virus replication machinery makes mistakes. Over time, these mistakes create mutations that result in a diverse population of viruses inside the host. Mutations that are neither lethal to the virus nor strongly beneficial can lead to minority variants that are minor members of the virus population. However, preparing samples for sequencing can also introduce errors that resemble minority variants, resulting in the inclusion of false-positive data if not filtered correctly. In this study, we aimed to determine the best methods for identification and quantification of these minority variants by testing the performance of seven commonly used variant-calling tools. We used simulated and synthetic data to test their performance against a true set of variants and then used these studies to inform variant identification in data from SARS-CoV-2 clinical specimens. Together, analyses of our data provide extensive guidance for future studies of viral diversity and evolution. When viruses replicate inside a host cell, the virus replication machinery makes mistakes. Over time, these mistakes create mutations that result in a diverse population of viruses inside the host. Mutations that are neither lethal to the virus nor strongly beneficial can lead to minority variants that are minor members of the virus population. However, preparing samples for sequencing can also introduce errors that resemble minority variants, resulting in the inclusion of false-positive data if not filtered correctly. In this study, we aimed to determine the best methods for identification and quantification of these minority variants by testing the performance of seven commonly used variant-calling tools. We used simulated and synthetic data to test their performance against a true set of variants and then used these studies to inform variant identification in data from SARS-CoV-2 clinical specimens. Together, analyses of our data provide extensive guidance for future studies of viral diversity and evolution.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Zinc-Embedded Polyamide Fabrics Inactivate SARS-CoV-2 and Influenza A Virus
    Gopal, Vikram
    Nilsson-Payant, Benjamin E.
    French, Hollie
    Siegers, Jurre Y.
    Yung, Wai-shing
    Hardwick, Matthew
    te Velthuis, Aartjan J. W.
    ACS APPLIED MATERIALS & INTERFACES, 2021, 13 (26) : 30317 - 30325
  • [42] Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients
    Bibert, Stephanie
    Guex, Nicolas
    Lourenco, Joao
    Brahier, Thomas
    Papadimitriou-Olivgeris, Matthaios
    Damonti, Lauro
    Manuel, Oriol
    Liechti, Robin
    Gotz, Lou
    Tschopp, Jonathan
    Quinodoz, Mathieu
    Vollenweider, Peter
    Pagani, Jean-Luc
    Oddo, Mauro
    Hugli, Olivier
    Lamoth, Frederic
    Erard, Veronique
    Voide, Cathy
    Delorenzi, Mauro
    Rufer, Nathalie
    Candotti, Fabio
    Rivolta, Carlo
    Boillat-Blanco, Noemie
    Bochud, Pierre-Yves
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [43] Cellular Sensors and Viral Countermeasures: A Molecular Arms Race between Host and SARS-CoV-2
    Sun, Haoran
    Chan, Jasper Fuk-Woo
    Yuan, Shuofeng
    VIRUSES-BASEL, 2023, 15 (02):
  • [44] The pitfalls of inferring virus-virus interactions from co-detection prevalence data: application to influenza and SARS-CoV-2
    de Celles, Matthieu Domenech
    Goult, Elizabeth
    Casalegno, Jean-Sebastien
    Kramer, Sarah C.
    PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2022, 289 (1966) : 20212358
  • [45] Clinical and epidemiological characteristics of respiratory syncytial virus, SARS-CoV-2 and influenza paediatric viral respiratory infections in southwest Saudi Arabia
    Asseri, Ali Alsuheel
    Al-Qahtani, Saleh M.
    Alzaydani, Ibrahim A.
    Al-Jarie, Ahmed
    Alyazidi, Noha Saad
    Alrmelawi, Ali A.
    Alqahtani, Alya Musfer
    Alsulayyim, Rahaf S.
    Alzailaie, Ameerah K.
    Abdullah, Dhay M.
    Ali, Abdelwahid S.
    ANNALS OF MEDICINE, 2025, 57 (01)
  • [46] Reemerging Influenza Virus Infections during the Dominance of the Omicron SARS-CoV-2 Variant in Mexico
    Rios-Silva, Monica
    Trujillo, Xochitl
    Huerta, Miguel
    Benites-Godinez, Veronica
    Guzman-Esquivel, Jose
    Bricio-Barrios, Jaime Alberto
    Mendoza-Cano, Oliver
    Lugo-Radillo, Agustin
    Murillo-Zamora, Efren
    PATHOGENS, 2022, 11 (10):
  • [47] Sequence signatures within the genome of SARS-CoV-2 can be used to predict host source
    Rudar, Josip
    Kruczkiewicz, Peter
    Vernygora, Oksana
    Golding, G. Brian
    Hajibabaei, Mehrdad
    Lung, Oliver
    MICROBIOLOGY SPECTRUM, 2024, 12 (04):
  • [48] Detection of Airborne Influenza A and SARS-CoV-2 Virus Shedding following Ocular Inoculation of Ferrets
    Belser, Jessica A.
    Sun, Xiangjie
    Kieran, Troy J.
    Brock, Nicole
    Pulit-Penaloza, Joanna A.
    Pappas, Claudia
    Basu Thakur, Poulami
    Jones, Joyce
    Wentworth, David E.
    Zhou, Bin
    Tumpey, Terrence M.
    Maines, Taronna R.
    JOURNAL OF VIROLOGY, 2022, 96 (24)
  • [49] Within-host genetic diversity of SARS-CoV-2 lineages in unvaccinated and vaccinated individuals
    Gu, Haogao
    Quadeer, Ahmed Abdul
    Krishnan, Pavithra
    Ng, Daisy Y. M.
    Chang, Lydia D. J.
    Liu, Gigi Y. Z.
    Cheng, Samuel M. S.
    Lam, Tommy T. Y.
    Peiris, Malik
    McKay, Matthew R.
    Poon, Leo L. M.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [50] Airborne virus shedding of the alpha, delta, omicron SARS-CoV-2 variants and influenza virus in hospitalized patients
    Ong, David S. Y.
    de Man, Peter
    Verhagen, Tim
    Doejaaren, Gerda
    Dallinga, Marloes A.
    Alibux, Esmee
    Janssen, Matthijs L.
    Wils, Evert-Jan
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (04)